Emily English - May 12, 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Emily English
Stock symbol
RNAC
Transactions as of
May 12, 2025
Transactions value $
$24,750
Form type
4
Date filed
5/14/2025, 04:15 PM
Previous filing
Apr 16, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
English Emily Chief Operations Officer C/O CARTESIAN THERAPEUTICS, INC., 7495 NEW HORIZON WAY, FREDERICK /s/ Matthew Bartholomae, Attorney-in-Fact for Emily English 2025-05-14 0002019791

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Options Exercise $24.8K +7.5K +15.71% $3.30 55.2K May 12, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNAC Stock Option (Right to Buy) Options Exercise -7.5K -17.91% 34.4K May 12, 2025 Common Stock 7.5K $3.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are currently fully vested and exercisable.
F2 On November 13, 2023, the issuer acquired the Delaware corporation which was then-known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the issuer's common stock in connection with the merger.